Marder SR

References (2)

Title : Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia - Walling_2016_Schizophr.Bull_42_335
Author(s) : Walling D , Marder SR , Kane J , Fleischhacker WW , Keefe RS , Hosford DA , Dvergsten C , Segreti AC , Beaver JS , Toler SM , Jett JE , Dunbar GC
Ref : Schizophr Bull , 42 :335 , 2016
Abstract :
PubMedSearch : Walling_2016_Schizophr.Bull_42_335
PubMedID: 26071208

Title : Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trial - Barch_2016_Prog.Neuropsychopharmacol.Biol.Psychiatry_71_66
Author(s) : Barch DM , Marder SR , Harms MP , Jarskog LF , Buchanan RW , Cronenwett W , Chen LS , Weiss M , Maguire RP , Pezous N , Feuerbach D , Lopez-Lopez C , Johns DR , Behrje RB , Gomez-Mancilla B
Ref : Prog Neuropsychopharmacol Biological Psychiatry , 71 :66 , 2016
Abstract :
PubMedSearch : Barch_2016_Prog.Neuropsychopharmacol.Biol.Psychiatry_71_66
PubMedID: 27371157